Caroline Hickman, Elizabeth Marks, Panu Pihkala et al.
1
Carrillo-Larco
1
Casadevall-Bellés S., Calleja R.
1
Cascioli Sharp, R.
1
Cash R et al.
1
Cashin, Jennifer
1
Cassels, Andrew
1
Castillo C., Villalobos Dintrans P. et al
1
Castro, A.
1
Catholic Agency for Overseas Development CAFOD
1
Catholic Bishops' Conference of England and Wales
1
Catholic Relief Services (CRS)
1
Catholic Relief Services, European Commission's Directorate-General for European Civil Protection and Humanitarian Aid Operations, International Organization for Migration
1
Cavallaro F. L., L. Benova, D. Macleod et. al.
1
Cawthrope, D.
1
CBM & Basic Needs UK in Uganda (BNUU)
1
CBM Australia
1
CBM International, HelpAge International,and Handicap International
1
CBR Africa Network, Handicap International
1
CBR Asia-Pacific Network
1
CDA Collaborative Learning Projects
1
CDAC Network
1
Cecchini, M.
1
Cecil Konijnendijk, Dikshya Devkota, Stephanie Mansourian & Christoph Wildburger (eds.)
1
cedpa (The Centre for Development and Population Activities)
1
Center for Innovation and Impact (CII), USAID
1
Center for International Peace Operations
1
Center for Operational Analysis and Research COAR
1
Center for Public Interest Communications, University of Florida
1
Centers for Disease C ontrol and Prevention (CDC )
1
Centers for Diseases Control and Prevention
1
Centers of Disease Control CDC
1
Central Asia-Caucasus Institute
1
Central Coast Children's Foundation
1
Central Statistical Office (CSO) Zambia, Ministry of Health (MOH) Zambia, and ICF, et al.
1
Central TB Division, Director ate General of Health Services, Ministry of Health & Family Welfare
1
Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare, Nirman Bhavan
1
Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare
1
Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT)
1
Centre for Antibiotic Resistance Research (CARe), University of Gothenburg
1
Centre for Development of Best Practices in Health (CDBPH)
1
Centre for Heath & Infectious Disease Research
1
Centre for Maternal and Newborn Health (CMNH), from the Liverpool School of Tropical Medicine (LSTM)
1
CERAH
1
Cerebral Palsy Alliance Research Foundation
1
Chagas Coalition
1
Challenge TB
1
Chama-Chiliba, C.
1
Chandani, Y.
1
Chang, Judy et al.
1
Channel Research
1
Charité
1
Charles B. Nemeroff
1
Charles Phiilipe de Lucena AlvesJoão de Deus Barreto Segundo, Gabriel Gonçalves da Costa et al.
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly ... certain antibiotic classes (beta-lactam antibacterials), most notably in the more prosperous states. Resistance follows in lock-step.more
Calls for greater implementation research (IR) capacity came in the wake of compelling evidence that implementation strategies are critically important for the dissemination and facilitation of evidence-informed policies and interventions to tackle noncommunicable diseases (NCDs), thereby improving ...outcomes for both individuals and populations. However, at present, implementation of evidence-based interventions and policies is challenged by a gap in lack of academic research on how these cost–effective recommended interventions can be implemented in the context of local settings, especially those of low and middle-income.more
The HIV drug resistance report 2021 summarizes findings from 38 countries that had finalized the surveys by the time of this report and shared data with WHO.
Pretreatment HIVDR to non-nucleoside reverse-transcriptase inhibitors (NNRTI) can affect more than 10% of adults starting therapy and is fo...und up to 3 times more often in people who had previous exposure to antiretroviral drugs. In addition, nearly half of infants newly diagnosed with HIV has HIVDR to NNRTI before initiating treatment.The high levels of observed NNRTI pretreatment HIVDR among emphasize the need to fast-track the transition to WHO-recommended dolutegravir-based ART.more
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...terns and distributions of new and longstanding HIV infections.
This technical guidance outlines best practices regarding the appropriate use of HIV recency assays for surveillance purposes and updates 2011 technical guidance from the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) on the use of HIV recency assays.more
A manual for impact assessments. The SCH Practical and Precision Assessment (SPPA) strategy is an evidence-based approach for conducting impact assessments for SCH. The SPPA was identified by programme managers and SCH experts from the African region as a feasible and sufficiently accurate approach ...after reviewing and discussing the results of a multi-country study. This manual describes the resulting Practical and Precision Assessments approach and includes a discussion of the underlying concepts, factors to consider when determining what approach is appropriate, and how to interpret the collected data. The manual also includes annexes with standard operating procedures for conducting the stool and urine analyses.more
The aims of these guidelines are to provide guidance to health-care providers (i.e. the end-users of these guidelines: physicians, nurses, pharmacists and caregivers) on the adequate relief of pain associated with cancer. They also assist policy-makers, programme managers and public health personnel... to create and facilitate appropriately balanced policies on opioids and prescribing regulations for effective and safe cancer pain management. Proper and effective stewardship of opioid analgesics in the cancer treatment setting is essential to ensure the safety of patients and to reduce the risk of diversion of medicine into society.
The goal of cancer pain management is to relieve pain to a level that allows for an acceptable quality of life.more
This publication is an updated version of the Management of Tuberculosis and HIV Coinfection clinical protocol released in 2007 by the WHO Regional Office for Europe. It is intended for all health care workers involved in preventing, diagnosing, treating and caring for people living with TB and HIV ...in the specific settings of the WHO European Region.more